UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
------------------
Date of Report (Date of earliest event reported):
October 22, 1997
-------------------
ANGEION CORPORATION
(Exact name of registrant as specified in its charter)
Minnesota 0-17019 41-1579150
(State or other of Incorporation) (Commission (I.R.S. Employer
File Number) (Identification No.)
3650 Annapolis Lane, Suite 170, Minneapolis, Minnesota 55447-5434
(Address of principal executive offices) (Zip Code)
(612) 550-9388
(Registrant's telephone number, including area code)
Not applicable.
(Former name or former address, if changed since last report)
<PAGE>
Item 8. Change in Fiscal Year.
On October 22, 1997, the Board of Directors of Angeion Corporation (the
"Registrant") determined to change its fiscal year-end from July 31 to December
31 and, accordingly, authorized the appropriate officers of the Registrant to
file with the Internal Revenue Service all requests, forms and other
documentation necessary in connection therewith. The Registrant intends to file
a transition report on Form 10-Q for the five-month transition period containing
unaudited financial statements for such transition period and unaudited
financial statements or information for the comparable period ended December 31,
1996.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ANGEION CORPORATION
By: /s/ Whitney A. McFarlin
--------------------------------------
Whitney A. McFarlin
President and Chief Executive Officer
Dated: October 23, 1997
<PAGE>
<TABLE>
<CAPTION>
INDEX TO EXHIBITS
Exhibit Description Method of Filing
- ------- ----------- ----------------
<S> <C> <C>
99.1. Press Release of the Registrant, dated October 23, 1997. Filed herewith.
</TABLE>
EXHIBIT 99.1
FOR IMMEDIATE RELEASE Contacts: David Christofferson, investors
Brenda Roth, media
ANGEION CORPORATION CHANGES
FROM FISCAL YEAR TO CALENDAR YEAR-END
MINNEAPOLIS (October 23, 1997) -- Angeion Corporation (Nasdaq:ANGN) announced
today that its Board of Directors has approved the change of its fiscal year to
a calendar year. The Board made its decision to be consistent with industry
standards, eliminate confusion among investors and analysts, and to align its
fiscal year with the calendar year-end of its pending U.S. joint venture with
ELA Medical.
The change will become effective immediately. Angeion's last Fiscal
year ended July 31, 1997. The Company will file a Transition Report on Form 10-Q
with the Securities and Exchange Commission for the five-month stub period
ending December 31, 1997.
On October 31, 1997, the Company announced its intention to form a
strategic collaboration with ELA Medical as part of an investment in Angeion by
Synthelabo, a subsidiary of cosmetics company L'Oreal. The closing of these
agreements will occur upon the expiration or early termination of the waiting
period under Hart-Scott-Rodino.
Angeion Corporation designs, develops and manufactures implantable
cardioverter defibrillators and catheter ablation systems for the
tachyarrhythmia (rapid irregular heartbeats) markets. Angeion's internet address
is: http://www.angeion.com.
-End-
